Stock report · Delisted · Nasdaq
Quipt Home Medical Corp. (QIPT)
3.65USD Delisted Final close · Mar 12, 2026

QIPT no longer trades. Quipt Home Medical was acquired in a take-private by affiliates of Kingswood Capital Management and Forager Capital Management for US$3.65 per share in cash under a plan of arrangement completed on March 16, 2026. The shares were delisted from Nasdaq and the Toronto Stock Exchange.
All prices on this page are historical. The last trade was on March 12, 2026, at $3.65.
QIPT stock price history
Final trading statistics
- Final close
- $3.65
- Final trading day
- Mar 12, 2026
- Market cap at delisting
- $162.30M
- Shares outstanding
- 44.46M
- Final 52-week range
- $1.35 – $3.65
- Avg. volume (final 3 mo.)
- 733,440
- All-time high
- $32.14 · Apr 2015
- All-time low
- $0.32 · Dec 2018
- Return since IPO
- +16.2%
- Beta
- 0.49
- Book value / share
- $2.29
- Price / book
- 1.59
About Quipt Home Medical Corp.
Quipt Home Medical Corp. was a provider of in-home medical equipment and respiratory care in the United States, headquartered in Wilder, Kentucky. The company was incorporated in 1993 and was formerly known as Protech Home Medical Corp., adopting the Quipt name in May 2021. Its shares were listed on both the Toronto Stock Exchange and the Nasdaq Stock Market under the symbol QIPT.
The business focused on patients with chronic conditions, with particular emphasis on respiratory disease, sleep apnea, reduced mobility and heart and pulmonary disease. Products and services included oxygen concentrators, CPAP and BiPAP equipment and masks, ventilators, nebulizers, hospital beds, wheelchairs, walkers, bathroom safety products and wound care supplies, along with home delivery, setup and patient support. Revenue came largely from reimbursement by government and commercial payors for equipment rentals and supplies.
Quipt grew in large part through acquisitions of regional home medical equipment providers across the United States, consolidating a fragmented industry. These acquisitions expanded its footprint across multiple states and added referral relationships with physicians and hospitals. The company described its strategy as combining local service with centralized operations and technology to improve patient outcomes and efficiency in the home care setting.
The company's equity story included its move to a Nasdaq listing alongside its Canadian listing, which broadened access for U.S. investors. Like other home medical equipment suppliers, Quipt operated under pressure from payor reimbursement changes and competitive bidding programs, and its results were sensitive to Medicare and commercial reimbursement rates.
In December 2025, Quipt entered into an arrangement agreement under which an entity formed by affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC would acquire all outstanding common shares for US$3.65 per share in cash. The transaction was structured as a plan of arrangement and was reviewed by a strategic transactions committee of the board, which received advice from independent financial advisors before recommending it.
The arrangement was completed on March 16, 2026. The purchaser, 1567208 B.C. Ltd., acquired all of the shares. Stock options were treated as fully vested and cashed out for their in-the-money value, with out-of-the-money options cancelled, and restricted share units were settled in cash at the deal price. Quipt shares stopped trading on Nasdaq upon completion and were due to cease trading on the Toronto Stock Exchange at the close of business on March 17, 2026. The company said it intended to cease to be a reporting issuer in Canada and to end its public reporting in the United States, and it is now privately held.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Distribution
- Headquarters
- Wilder, KY
- Employees
- 1,500
- IPO date
- May 27, 2021
- Delisted
- March 12, 2026
- SEC CIK
- 1540013
Quipt Home Medical financials before the delisting
The last 5 fiscal years Quipt Home Medical reported as a public company, fiscal year ending September.
QIPT revenue and net income
QIPT earnings per share
QIPT annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $341.40M | −$10.7M | −$0.25 |
| FY2024 | $245.91M | −$6.8M | −$0.15 |
| FY2023 | $211.68M | −$2.8M | −$0.14 |
| FY2022 | $139.86M | $4.8M | $0.15 |
| FY2021 | $102.35M | −$6.2M | −$1.01 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Quipt Home Medical stock FAQ
What happened to Quipt Home Medical stock?
Quipt Home Medical was acquired in a take-private by affiliates of Kingswood Capital Management and Forager Capital Management for US$3.65 per share in cash under a plan of arrangement completed on March 16, 2026. The shares were delisted from Nasdaq and the Toronto Stock Exchange. The final close was $3.65 on March 12, 2026.
Can I still buy QIPT stock?
No. QIPT is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on March 12, 2026.
What was the last price of QIPT?
QIPT last closed at $3.65 on March 12, 2026, which valued the company at about $162.30M.
How did Quipt Home Medical do in its last full fiscal year?
In fiscal 2025, its last full year as a public company, Quipt Home Medical reported revenue of $341.40M and net income of −$10.7M.
When did Quipt Home Medical go public?
Quipt Home Medical shares started trading on May 27, 2021.
QIPT no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.